These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Lasker JM, Wester MR, Aramsombatdee E, Raucy JL. Arch Biochem Biophys; 1998 May 01; 353(1):16-28. PubMed ID: 9578596 [Abstract] [Full Text] [Related]
11. Mephenytoin metabolism in vitro by human liver. Jurima M, Inaba T, Kalow W. Drug Metab Dispos; 1985 May 01; 13(2):151-5. PubMed ID: 2859161 [Abstract] [Full Text] [Related]
12. Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. Brian WR, Srivastava PK, Umbenhauer DR, Lloyd RS, Guengerich FP. Biochemistry; 1989 Jun 13; 28(12):4993-9. PubMed ID: 2669966 [Abstract] [Full Text] [Related]
13. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes. Thijssen HH, Flinois JP, Beaune PH. Drug Metab Dispos; 2000 Nov 13; 28(11):1284-90. PubMed ID: 11038154 [Abstract] [Full Text] [Related]
14. Oxidative metabolism of lansoprazole by human liver cytochromes P450. Pichard L, Curi-Pedrosa R, Bonfils C, Jacqz-Aigrain E, Domergue J, Joyeux H, Cosme J, Guengerich FP, Maurel P. Mol Pharmacol; 1995 Feb 13; 47(2):410-8. PubMed ID: 7870052 [Abstract] [Full Text] [Related]